BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26177500)

  • 21. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
    Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
    Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.
    Fang WB; Ireton RC; Zhuang G; Takahashi T; Reynolds A; Chen J
    J Cell Sci; 2008 Feb; 121(Pt 3):358-68. PubMed ID: 18198190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of EPHA2-siRNA plasmid on biological behavior of human osteosarcoma cells in vitro].
    Zhang LZ; Cai XS; Qian ZK; Mei J; Ma XH; Huang HY; Huang WD
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):566-9. PubMed ID: 18210872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy.
    Rajandram R; Bennett NC; Wang Z; Perry-Keene J; Vesey DA; Johnson DW; Gobe GC
    Pathology; 2012 Aug; 44(5):453-9. PubMed ID: 22810054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma.
    Goelden U; Pfoertner S; Hansen W; Toepfer T; von Knobloch R; Hofmann R; Buer J; Schrader AJ
    Urol Int; 2005; 75(3):269-76. PubMed ID: 16215318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual targeting of EphA2 and FAK in ovarian carcinoma.
    Shahzad MM; Lu C; Lee JW; Stone RL; Mitra R; Mangala LS; Lu Y; Baggerly KA; Danes CG; Nick AM; Halder J; Kim HS; Vivas-Mejia P; Landen CN; Lopez-Berestein G; Coleman RL; Sood AK
    Cancer Biol Ther; 2009 Jun; 8(11):1027-34. PubMed ID: 19395869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [FAK/c-Src signaling pathway mediates the expression of cell surface HSP90 in cultured human prostate cancer cells and its association with their invasive capability].
    Liu XG; Guo Y; Yan ZQ; Guo MY; Zhang ZG; Guo CA
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):340-4. PubMed ID: 21875461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
    Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
    APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Feb; 23(7):1448-56. PubMed ID: 14973554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression.
    Yu N; Fu S; Liu Y; Xu Z; Liu Y; Hao J; Wang B; Zhang A
    J Exp Clin Cancer Res; 2015 Sep; 34():107. PubMed ID: 26419932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In renal cell carcinoma the PTEN splice variant PTEN-Δ shows similar function as the tumor suppressor PTEN itself.
    Breuksch I; Welter J; Bauer HK; Enklaar T; Frees S; Thüroff JW; Hasenburg A; Prawitt D; Brenner W
    Cell Commun Signal; 2018 Jun; 16(1):35. PubMed ID: 29954386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD
    Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
    Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
    PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
    Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
    Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of caveolin-1 in fibronectin-induced mouse embryonic stem cell proliferation: role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways.
    Park JH; Ryu JM; Han HJ
    J Cell Physiol; 2011 Jan; 226(1):267-75. PubMed ID: 20658539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.